Stopping the Bleeding in Intracerebral Hemorrhage

Publisher Website
Google Scholar
Abstract
Beyond aggressive supportive care, clinicians have not had specific treatments to offer patients with intracerebral hemorrhage. The article by Mayer et al.1 in this issue of the Journal offers new hope for targeted therapy for this frequent cause of neurologic disability and death. Intracerebral hemorrhage is estimated to account for 10 to 15 percent of all strokes and to have a one-year mortality greater than 60 percent.2 In the Far East, intracerebral hemorrhage is even more common, accounting for almost 30 percent of strokes in China.3 Approximately 37,000 to 52,000 cases of intracerebral hemorrhage occur in the United States each . . .